Biotech / Medical: DYAX: Dyax Corp.  
Posts: 195 | Member SubjectMarks: 22 | No Bans

Share This Board Moderated By: SI (no user) -- (Moderated) -- Started: 11/25/2000  Revision History

This message board is intended for discussion of DYAX: Dyax Corp..
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
1956:32AM Dyax and Sigma-Tau announce partnership to develop and commercialize subcmlkr-06/21/2010 11:07 AM
194>They'd better stick to what they know best - antibiotics.< Actually,DewDiligence_on_SI-04/01/2010 05:56 PM
193They'd better stick to what they know best - antibiotics. idos-04/01/2010 01:39 PM
192Cubist's track record with inlicensing has been atrocious. rkrw-04/01/2010 09:15 AM
191It was no big surprised if even I could see it coming back in Dec: investorshubidos-04/01/2010 08:26 AM
1901K shares of it were hanging on arca at about the close for a few minutes after scaram(o)uche-03/31/2010 04:20 PM
189>>Cubist Pharmaceuticals to End Development of CB-500,929 Decision followstuck-03/31/2010 04:13 PM
188CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX - News) announced todnigel bates-12/02/2009 08:08 AM
187CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX - News) announced tonigel bates-10/13/2009 08:01 AM
186>>Dyax Receives Complete Response Letter from FDA for DX-88 in Acute Attactuck-03/26/2009 04:14 PM
185DYAX said in its Q4 CC that the focus of their discussions with FDA is a "sidos-02/25/2009 03:43 PM
184Dyax Announces Expansion of Antibody Discovery Collaboration with Biogen Idec Thnigel bates-02/05/2009 11:11 AM
183Panel voted 6-5 (2 abstentions) to approve. They voted (8-5) that the drug is efidos-02/05/2009 12:36 AM
182Yes or no vote? First notice from ScotTrade said this had failed on a 5 to 6 voSteve Lokness-02/04/2009 04:31 PM
181Cinryze was approved as an orphan drug for prophylactic treatment of HAE and sinidos-11/23/2008 02:37 AM
180Hasn't Lev already beat them to market and attained the orphan exclusivity? mcbio-11/22/2008 11:35 PM
179FDA has accepted for filing the BLA for DX-88 (ecallantide) for the treatment ofidos-11/21/2008 03:57 PM
178Dyax announced completion of BLA for DX-88 for HAE and has requested Priority Reidos-09/24/2008 11:19 AM
177DX-88 has successfully completed EDEMA4 trial. No allergic reactions were found.idos-08/18/2008 04:12 PM
176GENZ once owned half the rights to this program but relinquished them to Dyax foDewDiligence_on_SI-04/24/2008 11:38 PM
175Thought I'd mention Jerini's whiff, though, since no one else has here. DewDiligence_on_SI-04/24/2008 03:55 PM
174Maybe the market is negative because Dyax reported a net loss of $21.3M, ended Qidos-04/24/2008 03:39 PM
173Del idos-04/24/2008 03:37 PM
172Interesting that the market doesn't think much of this deal. Perhaps becaustuck-04/24/2008 03:19 PM
171Dyax, Cubist Ink R&D Deal for Blood-Loss Drug  Elizabetidos-04/24/2008 03:08 PM
170Companies line up for hereditary angioedema market Brady Huggett | NATURE BIOTEidos-04/14/2008 02:09 PM
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2014 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.